PROVENTION BIO, INC.
PRVB evidence brief
What we can confirm
- BioSniper Score:
- 9.9 / 10
- Market Cap:
- $2.37B
- Lead Asset:
- ordesekimab (Phase 2)
What it means
What to watch
Prepared research question
What matters most for PRVB—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$2.37B
Cash Runway
—
Lead Asset
ordesekimab (Phase 2)
Next Catalyst
—
Tracking 6 pipeline candidates · 1 clinical trial · 1 FDA decision for PROVENTION BIO, INC..
Run PROVENTION BIO, INC. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available PROVENTION BIO, INC. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
Cash runway data unavailable
Financial health data unavailable
Lead: Approved
6 candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Pipeline
Regulatory
Financials
Short Interest
as of May 22, 2026- % of float
- 0.0%
- Days to cover
- 0.0
- Shares short
- 12,012
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
PRVB short interestGovernance
Frequently asked questions
What is PROVENTION BIO, INC.'s lead drug candidate?
PROVENTION BIO, INC.'s most advanced tracked candidate is ordesekimab (Phase 2) for Gluten-free diet non-responsive celiac disease (NRCD).
Who is the CEO of PROVENTION BIO, INC.?
Mr. Kurtis James Wolf is the chief executive officer of PROVENTION BIO, INC. (PRVB).
Where is PROVENTION BIO, INC. headquartered?
PROVENTION BIO, INC. (PRVB) is headquartered in Shelton, CT, United States.
What therapeutic areas does PROVENTION BIO, INC. focus on?
PROVENTION BIO, INC. develops therapies across Oncology, Immunology, Metabolic.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.